Frankfurt
23.12.24
08:15 Uhr
0,058 Euro
+0,001
+0,88 %
+0,88 %
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,055 | 0,080 | 23.12. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Ventripoint Diagnostics Ltd (2): Ventripoint plans to extend debenture financing | 1 | Stockwatch | ||
| Fr | Ventripoint Diagnostics Ltd.: Ventripoint Announces Extension of Non-Brokered Convertible Debenture Private Placement | 1 | TheNewswire | ||
| 18.12. | Ventripoint Diagnostics Ltd (2): Ventripoint, Ascend sign term sheet for licensing deal | 1 | Stockwatch | ||
| 18.12. | Ventripoint Diagnostics Ltd.: VENTRIPOINT and ASCEND Cardiovascular sign Term Sheet for integration of VMS+ into ASCEND's Gen3Echo platform | 3 | TheNewswire | ||
| 17.12. | Ventripoint Diagnostics Ltd (2): Ventripoint closes first tranche of debenture financing | 1 | Stockwatch | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 17.12. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of First Tranche of Amended Non-Brokered Convertible Debenture Private Placement | 1 | TheNewswire | ||
| 13.12. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 112,210 shares for debt | 1 | Stockwatch | ||
| 10.12. | Ventripoint Diagnostics Ltd.: Ventripoint Issue Shares for Payment of Debenture Interest and Amends Terms of Convertible Debenture Offering | 1 | TheNewswire | ||
| 04.12. | Ventripoint Diagnostics Ltd.: Ventripoint Provides Corporate Update and Announces Shareholder Teleconference | 4 | TheNewswire | ||
| 28.11. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics 128,900 shares for debt | 3 | Stockwatch | ||
| 22.11. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of Debt Settlement Agreements | 1 | TheNewswire | ||
| 19.11. | Ventripoint Announces New Sales Program to Accelerate Growth in U.S. Market for AI-Powered Echocardiography Solutions | 1 | iNVEZZ.com | ||
| 19.11. | Ventripoint Diagnostics Ltd.: Ventripoint Announces New Sales Program to Accelerate Growth in U.S. Market for AI-Powered Echocardiography Solutions | 1 | TheNewswire | ||
| 16.11. | Ventripoint Diagnostics Ltd (2): Ventripoint 2,845,771-share private placement | 2 | Stockwatch | ||
| 14.11. | Ventripoint Diagnostics Ltd (2): Ventripoint closes final tranche of private placement | 1 | Stockwatch | ||
| 14.11. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of Second and Final Tranche of Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption | 1 | TheNewswire | ||
| 06.11. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Amended Non-Brokered Convertible Debenture Private Placement and Shares for Debt Transaction | 2 | TheNewswire | ||
| 24.10. | Ventripoint Diagnostics Ltd (2): Ventripoint receives CE Mark certification for VMS+4.0 | 2 | Stockwatch | ||
| 24.10. | Ventripoint to debut new AI heart-scanning tech in Europe | 3 | The Market Herald Canada | ||
| 24.10. | Ventripoint Diagnostics Ltd.: Ventripoint Receives EU CE Mark for Next Generation, AI-powered Heart-scanning Technology | 1 | TheNewswire |
Seite:
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 0,950 | -1,66 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Full Results from Phase 2 KARISMA-Endoxifen Study Demonstrating Statistically Significant Reductions in Mammographic Breast Density | 1 MG Dose (Z)-Endoxifen Shows Potential as a Well-Tolerated, Preventative Therapy for Premenopausal Women at Risk of Developing Breast Cancer Data to be Presented in a Poster Spotlight Session During... ► Artikel lesen | |
| TANDEM DIABETES | 34,200 | +7,45 % | Tandem Diabetes Care Aktie: Einordnung der Finanzdaten | Die Aktie von Tandem Diabetes Care verzeichnete am 07. Dezember 2024 einen minimalen Kursrückgang von 0,04 Prozent auf 28,46 EUR. Das Medizintechnikunternehmen, das sich auf Insulinverabreichungssysteme... ► Artikel lesen | |
| VERU | 0,611 | -2,24 % | Veru (NASDAQ:VERU) Receives "Buy" Rating from HC Wainwright | ||
| MOLINA HEALTHCARE | 283,30 | +0,07 % | $100 Invested In Molina Healthcare 20 Years Ago Would Be Worth This Much Today | ||
| CLOVER HEALTH INVESTMENTS | 3,072 | -2,38 % | Clover Health Investments, Corp.: Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer | FRANKLIN, Tenn., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a leading AI-powered physician enablement platform, today announced the appointment of David Tsay M.D.... ► Artikel lesen | |
| TEMPUR SEALY | 54,00 | +0,93 % | Tempur Sealy International Target of Unusually High Options Trading (NYSE:TPX) | ||
| SHL TELEMEDICINE | 2,900 | 0,00 % | SHL Telemedicine Ltd.: SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine | David Arnon held senior leadership and CEO roles within the healthcare insurance industry at Harel Insurance and Clal Insurance, two of the largest insurance groups in Israel
SHL Telemedicine Ltd.... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 3,690 | 0,00 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
| SEMLER SCIENTIFIC | 59,00 | -0,84 % | Semler Scientific, Inc. (SMLR) Among Companies Holding Bitcoin on Their Balance Sheets | ||
| SMILEDIRECTCLUB | 0,004 | 0,00 % | Are you a former SmileDirectClub customer? You might be eligible for a refund | ||
| NEURONETICS | 1,292 | +1,10 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company") today announced the granting of inducement awards to new employees as described below. In accordance... ► Artikel lesen |
VENTRIPOINT DIAGNOSTICS LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +0,88 % bei einem Aktienkurs von 0,058 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENTRIPOINT DIAGNOSTICS LTD finden Sie auf Wallstreet Online.
